AbCellera Biologics Inc.
ABCL
$10.97
$0.625.94%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 540.10M | 504.73M | 533.83M | 495.67M | 553.08M |
| Total Receivables | 95.43M | 115.73M | 153.40M | 159.36M | 153.37M |
| Inventory | 7.58M | 7.86M | 6.34M | -- | -- |
| Prepaid Expenses | 11.12M | 11.28M | 9.67M | 15.11M | 10.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.00M | 25.00M | 25.00M | 25.00M | 25.00M |
| Total Current Assets | 679.23M | 664.60M | 728.23M | 695.14M | 742.15M |
|
|
|||||
| Total Current Assets | 679.23M | 664.60M | 728.23M | 695.14M | 742.15M |
| Net Property, Plant & Equipment | 416.68M | 422.81M | 428.00M | 427.36M | 424.02M |
| Long-term Investments | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Goodwill | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Total Other Intangibles | 36.53M | 37.46M | 38.38M | 39.32M | 40.26M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.70M | 36.64M | 19.65M | 53.07M | 57.45M |
| Total Assets | 1.31B | 1.31B | 1.36B | 1.36B | 1.40B |
|
|
|||||
| Total Accounts Payable | 12.11M | 20.81M | 25.23M | 31.77M | 32.04M |
| Total Accrued Expenses | 6.08M | 3.93M | 10.76M | 7.23M | 4.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.67M | 5.87M | 5.82M | 5.17M | 4.90M |
| Total Finance Division Other Current Liabilities | 29.34M | 16.69M | 22.51M | 24.63M | 25.12M |
| Total Other Current Liabilities | 29.34M | 16.69M | 22.51M | 24.63M | 25.12M |
| Total Current Liabilities | 53.19M | 47.29M | 64.31M | 68.80M | 67.02M |
|
|
|||||
| Total Current Liabilities | 53.19M | 47.29M | 64.31M | 68.80M | 67.02M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 129.95M | 134.31M | 137.40M | 137.05M | 137.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 228.42M | 187.43M | 188.34M | 186.10M | 190.78M |
| Total Liabilities | 411.56M | 369.03M | 390.05M | 391.95M | 394.99M |
|
|
|||||
| Common Stock & APIC | 1.03B | 1.01B | 1.00B | 987.27M | 973.15M |
| Retained Earnings | -128.07M | -72.65M | -29.48M | -20.54M | 36.58M |
| Treasury Stock & Other | -3.15M | -2.42M | -4.23M | -2.70M | -2.66M |
| Total Common Equity | 896.02M | 938.08M | 966.90M | 964.04M | 1.01B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 896.02M | 938.08M | 966.90M | 964.04M | 1.01B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 896.02M | 938.08M | 966.90M | 964.04M | 1.01B |
|
|
|||||